McKesson/$MCK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About McKesson
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Ticker
$MCK
Sector
Primary listing
NYSE
Employees
44,000
Headquarters
Website
McKesson Metrics
BasicAdvanced
$88B
28.51
$24.95
0.51
$2.84
0.40%
Price and volume
Market cap
$88B
Beta
0.51
52-week high
$737.89
52-week low
$464.42
Average daily volume
865K
Dividend rate
$2.84
Financial strength
Current ratio
0.883
Quick ratio
0.475
Long term debt to equity
-971.842
Total debt to equity
-1,150.985
Dividend payout ratio (TTM)
11.16%
Interest coverage (TTM)
21.41%
Profitability
EBITDA (TTM)
5,607
Gross margin (TTM)
3.45%
Net profit margin (TTM)
0.84%
Operating margin (TTM)
1.36%
Effective tax rate (TTM)
22.52%
Revenue per employee (TTM)
$8,580,000
Management effectiveness
Return on assets (TTM)
4.17%
Return on equity (TTM)
-298.75%
Valuation
Price to earnings (TTM)
28.509
Price to revenue (TTM)
0.238
Price to book
-45.21
Price to tangible book (TTM)
-5.05
Price to free cash flow (TTM)
15.842
Free cash flow yield (TTM)
6.31%
Free cash flow per share (TTM)
44.906
Dividend yield (TTM)
0.40%
Forward dividend yield
0.40%
Growth
Revenue change (TTM)
20.35%
Earnings per share change (TTM)
11.87%
3-year revenue growth (CAGR)
12.04%
10-year revenue growth (CAGR)
7.51%
3-year earnings per share growth (CAGR)
39.24%
10-year earnings per share growth (CAGR)
13.56%
3-year dividend per share growth (CAGR)
14.74%
10-year dividend per share growth (CAGR)
11.46%
What the Analysts think about McKesson
Analyst ratings (Buy, Hold, Sell) for McKesson stock.
Bulls say / Bears say
McKesson increased its fiscal 2026 earnings outlook to $37.10–$37.90 per share, signaling 12%–15% expected growth and management's confidence in sustained demand for specialty drugs and continued operational gains (Reuters).
For Q1 of fiscal 2026, McKesson posted revenue of $97.83 billion, exceeding analyst expectations of $96.08 billion. The U.S. pharmaceutical division recorded $89.95 billion in sales, marking a 25% increase from the previous year, driven by greater prescription volumes and rising specialty product distribution (Reuters).
The company reaffirmed its intention to spin off the Medical-Surgical Solutions division into a standalone company, aiming to sharpen focus on its higher-margin core drug distribution business and enhance shareholder value (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2025.
McKesson Financial Performance
Revenues and expenses
McKesson Earnings Performance
Company profitability
McKesson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Oct1
McKesson
DividendPayment
$0.82Per share
FAQs
What’s the current market cap for McKesson stock?
McKesson (MCK) has a market cap of $88B as of September 16, 2025.
What is the P/E ratio for McKesson stock?
The price to earnings (P/E) ratio for McKesson (MCK) stock is 28.51 as of September 16, 2025.
Does McKesson stock pay dividends?
Yes, the McKesson (MCK) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $2.84 and the yield is 0.4%. McKesson has a payout ratio of 11.16% on a trailing twelve-month basis.
When is the next McKesson dividend payment date?
The next McKesson (MCK) dividend payment is scheduled for October 01, 2025.
What is the beta indicator for McKesson?
McKesson (MCK) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.